“Rybelsus has the active ingredient semaglutide and inactive ingredients including magnesium stearate, microcrystalline cellulose, povidone, and salcaprozate sodium (SNAC),” explains Dr ...

Rybelsus (semaglutide) and Ozempic (semaglutide) are brand-name drugs. They’re both prescribed to help manage blood sugar levels in adults with type 2 diabetes. Continue reading to learn about ...

The FDA approval last Friday of Novo Nordisk’s Rybelsus as the first orally-active GLP-1 agonist is only the first challenge facing the company as it pursues its blockbuster sales targets for ...

Novo acquired the SNAC (Sodium N-[8-(2-hydroxybenzoyl)amino]caprylate) technology which is used in Rybelsus and has developed ...

The EMA's main advisory committee has backed approval of Novo Nordisk's oral GLP-1 agonist Rybelsus, a key pipeline drug in its type 2 diabetes franchise. Rybelsus (semaglutide) is the first GLP-1 ...